DRW Securities’s Biomerica BMRA Stock Holding History

DRW Securities’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,925	Closed	-$42.7K	–	1313
2025 Q4	$42.7K	Buy	16,925 +6,533	+63%	+$17K	﹤0.01%	1126
2025 Q3	$29.4K	Buy	+10,392	New	+$32.9K	﹤0.01%	1242

Other funds holding BMRA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

DRW Securities's BMRA Position: Q1 2026 in Review

DRW Securities sold out of Biomerica (BMRA) in Q1 2026, closing a stake of 16,925 shares — an estimated $42.7K sold.

DRW Securities first reported a position in BMRA in Q3 2025 and held it in 2 quarters. The position peaked at $42.7K in Q4 2025. 11 funds tracked by Wall St. Rank hold BMRA as of Q1 2026.

DRW Securities reported no remaining Biomerica position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 16,925 Biomerica shares in Q1 2026, an estimated $42.7K.
DRW Securities first reported a position in Biomerica in Q3 2025 and held it in 2 quarters.
DRW Securities's Biomerica position peaked at $42.7K in Q4 2025.
11 funds tracked by Wall St. Rank held Biomerica as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.